SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-038412
Filing Date
2021-03-18
Accepted
2021-03-18 16:53:44
Documents
3
Effectiveness Date
2021-03-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2110156d1_s8.htm S-8 45688
2 EXHIBIT 5.1 tm2110156d1_ex5-1.htm EX-5.1 6577
3 EXHIBIT 23.1 tm2110156d1_ex23-1.htm EX-23.1 2225
  Complete submission text file 0001104659-21-038412.txt   55503
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254454 | Film No.: 21755006
SIC: 2834 Pharmaceutical Preparations